Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Desmorat

Influence of HCV Genotype 1 Subtypes on the Virus Response to PEG Interferon Alpha-2a Plus Ribavirin Therapy

Journal of Medical Virology

Virology

Infectious Diseases

2011

English

Related publications

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

English

Mixed Treatment Comparisons to Compare Simeprevir With Boceprevir and Telaprevir in Combination With Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected With Genotype 1 Hepatitis C Virus (Hcv)

English

Characterization of Nonrapid Virologic Response Patients Infected With HCV Genotype 1 Who May Relapse After Standard Therapy With Peginterferon Plus Ribavirin

Journal of Viral Hepatitis

English

Therapeutic Response to Peg-Ifn-Alpha-2b and Ribavirin in HIV/HCV Co-Infected African-American and Caucasian Patients as a Function of HCV Viral Kinetics and Interferon Pharmacodynamics

English

Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin

Alimentary Pharmacology and Therapeutics

English

Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy

English

The Importance of IL28B Polymorphism in Response to Pegylated Interferon Α and Ribavirin in Chronic Hepatitis Caused by HCV Genotype 1b

Przeglad Gastroenterologiczny

Gastroenterology

2012

English

Induction Pegylated Interferon Alfa-2a and High Dose Ribavirin Do Not Increase SVR in Heavy Patients With HCV Genotype 1 and High Viral Loads

English

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Current Therapeutic Research

Pharmacology

2005

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by H. Desmorat

Influence of HCV Genotype 1 Subtypes on the Virus Response to PEG Interferon Alpha-2a Plus Ribavirin Therapy

Related publications

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

Mixed Treatment Comparisons to Compare Simeprevir With Boceprevir and Telaprevir in Combination With Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected With Genotype 1 Hepatitis C Virus (Hcv)

Characterization of Nonrapid Virologic Response Patients Infected With HCV Genotype 1 Who May Relapse After Standard Therapy With Peginterferon Plus Ribavirin

Therapeutic Response to Peg-Ifn-Alpha-2b and Ribavirin in HIV/HCV Co-Infected African-American and Caucasian Patients as a Function of HCV Viral Kinetics and Interferon Pharmacodynamics

Ribavirin Dosage in Patients With HCV Genotypes 2 and 3 Who Completed Short Therapy With Peg-Interferon Α-2b and Ribavirin

Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy

The Importance of IL28B Polymorphism in Response to Pegylated Interferon Α and Ribavirin in Chronic Hepatitis Caused by HCV Genotype 1b

Induction Pegylated Interferon Alfa-2a and High Dose Ribavirin Do Not Increase SVR in Heavy Patients With HCV Genotype 1 and High Viral Loads

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia